We observed up-regulation of ALAS2 only in the three erythroid leukemia lines included in the panel [MEL, K562, and human erythroleukemia (HEL)] and not in cell lines derived from other lineages (Fig. 1F). This evidence concerns the gene ALAS2 and leukemia.